United States Non-Invasive Prenatal Testing (NIPT) Market Analysis United States Non-Invasive Prenatal Testing (NIPT) | Page 5

United States Non –Invasive Prenatal Test(NIPT) Market
8.
9.
7.4 Exclusive Agreement
7.5 Licensing Agreement
7.6 Distribution Agreement
7.7 Partnership Deals
Non–Invasive Prenatal Testing Implementation – High–Income Countries
8.1.1 Clinical Issues
8.1.2 Ethical Issues
8.1.3 Legal and Regulatory Issues
Key Companies Analysis
9.1
Sequenom Laboratories (LabCorp)
9.1.1 Business Overview
9.1.2 NIPT Test Portfolio
9.1.3 NIPT Test Analysis (Volume and Value)
9.1.3.1 Overall NIPT Test Volume & Forecast
9.1.3.2 Overall NIPT Test Market Revenue & Forecast
9.1.4 Sequenom Laboratories – International Distributors
9.1.5 NIPT Test - Latest Development & Trends
9.2
Ariosa Diagnostics (Roche)
9.2.1 Business Overview
9.2.2 NIPT Test Portfolio
9.2.3 NIPT Test Analysis (Volume and Value)
9.2.3.1 Overall NIPT Test Volume & Forecast
9.2.3.2 Overall NIPT Test Market Revenue & Forecast
9.2.4
9.3
NIPT Test - Latest Development & Trends
Illumina
9.3.1 Business Overview
9.3.2 NIPT Test Portfolio
9.3.3 NIPT Test Analysis (Volume and Value)
9.3.3.1 Overall NIPT Test Volume & Forecast
9.3.3.2 Overall NIPT Test Market Revenue & Forecast
9.3.4
9.4
NIPT Test - Latest Development & Trends
Natera
9.4.1 Business Overview
9.4.2 NIPT Test Portfolio
© DPI Research
www.dpiresearch.com
Page 5 of 9